The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNature Group Regulatory News (NGR)

  • There is currently no data for NGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

2 Jun 2008 07:00

RNS Number : 6890V
Nature Technology Solutions Limited
02 June 2008
 



Nature Technology Solutions Limited

Preliminary Unaudited Results for the Year ended 31st December 2007

Contract awarded for deployment of treatment unit in the North Sea

Financial Highlights 2007

Maiden Group Profit, pre-tax of £391,984 , post-tax of £312,111

Turnover up 89% to £2.25m

Operating profit up 110% to £1.12m

Earnings before interest, tax, depreciation and amortisation ('EBITDA') of £0.56m

Chairman's Statement

Results

I am delighted to report our first year of Group profits, which is a tribute to the application of our technology, enthusiasm of the team, and indeed a reward for the patience of our shareholders over the last seven years. 

Pretax profits for the Group in 2007 amounted to £391,984 (2006 - loss £104,368) from attributable revenues of £2,254,234 (2006 - £1,191,241) which is an excellent outcome for the year, and demonstrated the earnings capacity of our technologies in both Norway and Gibraltar. This translated into post tax profits of £312,111 compared to a £73,298 loss in 2006. Revenues for 2007 included two contracts, one in the north of Norway and the other in Gibraltar, which could be described as 'non-recurring', and which contributed significantly to the year's profits. However, we believe that the Group is now sufficiently well established and broadly based to win such major contracts on a regular basis.

Of the operating profit of £1.12m, Norway contributed £0.7m of which our 40% owned quayside joint venture in Tananger provided £0.18m in earnings to our Group , partly due to favorable prices and volumes in 2007, which may take some effort to repeat in 2008.

The balance of operating profit, £0.42m, was generated from our share of earnings achieved by our 50% owned Gibraltar company, Slop Oil Reception and Treatment Ltd ('SORT'), which is the port oil waste reception facility in that location, and indeed was the original foundation for the Group. The substantial improvement in both turnover and profits were also enabled by completing the re-siting and enlargement of facilities in the Port of Gibraltar which now offer over 6,000 cubic metres of storage for reception and treatment of oily wastewaters. Its reputation as a reception facility at the entrance to the Miditerranean was further enhanced by the award of the new EU IPPC waste licence and ISO 9001 accreditation. The substantial profit earned by SORT and near completion of its major capital expenditure enabled the company to pay its first dividend to the Group, a policy which is expected to continue.

Other significant developments in 2007

Purchase of 100% of Northern Treatment AS

Shareholders will be aware that over the last 3 years, we have invested in the development of a new Offshore Treatment Unit ('OTU') which was designed to treat rig and platform generated wastes offshore in the North Sea (and, if successful, worldwide). The technology was designed to treat the waste, and then discharge clean water to sea under the new and demanding standards in place, thus saving very substantial transport and disposal costs ashore and contributing to the 'greener' environment. This project was financed through our 60% owned Norwegian company, Northern Treatment AS, but in September last year we bought out our 40% partner's interest to give us full control over final development, marketing. and ongoing OTU operations in Norway.

Near sale of our Gibraltar investment

In October last year we received an unsolicited approach from a well established Greek 'slops' operator for our 50% interest in SORT, the Gibraltar joint venture. After exhaustive negotiation we agreed a price of $6m (about £3m) and, having signed a Memorandum of Understanding, commenced the sale process.. The offer capitalised the value of our Gibraltar investment at an effective amount of 0.6p per ordinary share and potentially enabled a substantial return of cash to shareholders and retention of our core Norwegian interests. In the event, we withdrew from this transaction in March and, having established a fundamental value on SORThave identified opportunities to expand our Ports operations in the region and elsewhere.

Current trading and prospects

Norway

After more than a year of discussions and negotiations we are delighted to report the contracted deployment of our OTU on a major North Sea drilling rig, operating offshore Norway.. The unit is currently being installed and will be tested to ensure that our rigorous targets for treatment of offshore wastes, and their discharge to sea as clean water, are met in the field. The contract is on a 'day rate' basis for equipment, chemicals and operating staff for an initial period of 3 months . A successful outcome to these tests will enable possible extension of this contract and acceleration of marketing to other rigs and platforms in the North Sea and elsewhere.

Whilst it will be challenging to maintain the 2007 profitability of our joint venture quayside plant in Tananger, its considerably enhanced capacity should enable increased throughput if waste volumes are available. The company, SAR Treatment AS ('SART'), paid its maiden dividend to the Group this year from 2007 profits and we believe it should be a good source of future cash flow. 

Internationally, we have been negotiating a contract for the design, build and delivery of a treatment unit to a man-made drilling island in Kazakhstan which, if awarded, would generate revenues for 2008 and onwards .

Gibraltar

Since 2007 we have further increased our reception tankage from 6,000 to approximately 7,000 tonnes and now have the facilities and approvals to accept 'low flash' wastewaters resulting from crude oil tanker washings. This has already resulted in an increase of approximately 60% in volumes for the first 5 months of 2008. Whilst certain of 2007's one-off revenues will not recur this year, SORT's budget is for gross revenues to equal or exceed those achieved last year. An additional location from which waste would be generated for SORT's reception and treatment operations is under active discussion, although will not impact profitability in the current year.

UK and Middle East

We are hopeful of establishing a joint venture facility in Aberdeen similar to our quayside plant in Norway, in order to service the UK North Sea oil industry. Also in Aberdeen we have been discussing the acquisition of a soil remediation solutions provider which, if completed, would extend our technology base into the UK and provide another environmental leg to the Group.

A recently signed joint venture with a major US Group could also introduce us to potential business in the treatment of maritime wastewaters in the Gulf region of the Middle East.

Staff

As will be evident from the growing pace of activities within all areas of the Group over the last year, staff have been continually challenged by the demands of finding treatment solutions, the design and production of complex equipment and its commissioning, and the hours involved in interfacing with clients. All have risen to the occasion and I would like to thank them for their commitment on behalf of shareholders, and hope that they are enjoying the environment they have helped to create. The current, and the next, phases of growth require additional key staff in many areas of the business and I trust that we can attract the additional talent necessary to take the next quantum leap forward.

 

Richard Eldridge Chairman 2nd June 2008

NATURE TECHNOLOGY SOLUTIONS LIMITED

CONSOLIDATED INCOME STATEMENT

FOR THE YEAR TO 31ST DECEMBER 2007

Unaudited

Audited

Year to

Year to

31/12/2007

31/12/2006

£

£

REVENUE

Revenues from operations

1,030,888

264,036

Joint ventures

1,223,346

927,205

 

 

2,254,234

1,191,241

COST OF SALES

Direct cost of operations

(517,375)

(225,854)

Joint ventures

(616,019)

(431,820)

 

 

OPERATING PROFIT 

1,120,840

533,567

Other income

18,962

7,535

Administrative expenses

(559,307)

(473,738)

Finance costs

(24,496)

(20,622)

Depreciation and goodwill impairment cost

(164,015)

(151,110)

 

 

Profit / (Loss) on ordinary activities before taxation

391,984

(104,368)

Minority interest

-

21,354

Taxation on profit /(loss) on ordinary activities

(79,873)

9,716

 

 

Profit / (Loss) for the financial period

312,111

(73,298)

Basic profit / (loss)per share

0.00064

(0.00017)

NATURE TECHNOLOGY SOLUTIONS LIMITED

CONSOLIDATED BALANCE SHEET AT 31ST DECEMBER 2007

Unaudited

Audited

As at 

As at

31/12/07

31/12/06

£

£

ASSETS:

NON CURRENT ASSETS

Tangible assets

678,762

434,450

Intangible assets

152,172

148,429

Investments

1,954,553

1,715,856

Deferred tax assets

85,047

110,888

 

 

Total non current assets

2,870,534

2,409,623

CURRENT ASSETS

Debtors

305,780

205,391

Balance at bank

268,375

211,902

 

 

Total current assets

574,155

417,293

 

 

TOTAL ASSETS

3,444,689

2,826,916

LIABILITIES:

CURRENT LIABILITIES

(323,304)

(325,896)

NON CURRENT LIABILITIES

(227,085)

(206,551)

 

 

NET ASSETS

2,894,300

2,294,469

EQUITY

Called up share capital

49,239

43,959

Share premium account

1,978,636

1,696,196

Capital Reserve

2,864,130

2,864,130

Profit and loss account

(1,997,705)

(2,309,816)

 

 

TOTAL EQUITY

2,894,300

2,294,469

NATURE TECHNOLOGY SOLUTIONS LIMITED

CONSOLIDATED CASH FLOW STATEMENT

FOR THE YEAR TO 31ST DECEMBER 2007

Unaudited

Audited

Year to

year to

31/12/07

31/12/06

£

£

Reconciliation of operating profit to net cash flow from operating activities:

Profit for the year/(loss) before tax

391,984

(73,298)

Adjustments for:

Depreciation

24,567

13,027

(Increase)/Decrease in debtors

(100,389)

(58,082)

Decrease/(increase) in deferred tax

25,841

(6,509)

(Decrease)/increase in creditors

(61,931)

173,989

 

 

Net cash from operating activities

280,072

49,127

Financing activities:

Issuing of ordinary share capital

287,720

215,481

Investing activities:

Acquisition of intangible fixed assets

(268,879)

(54,032)

Acquisition of tangible fixed assets

(3,743)

(415,181)

Increase in investments

(238,697)

(147,575)

 

 

Increase/(Decrease) in cash and cash equivalents

56,473

(352,180)

Analysis of cash and cash equivalents during the year

Balance at start of period

211,902

564,082

Increase/(decrease) in cash and cash equivalents

56,473

(352,180)

 

 

Balance at end of period

268,375

211,902

Notes to the accounts

1. The calculation of profit per share has been based on the profit for the period and the average 487,993,384 Ordinary Shares in issue throughout the period.

2. These unaudited results have been prepared on the basis of the accounting policies adopted in the accounts to 31 December 2006.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR AMMFTMMBJBRP
Date   Source Headline
27th Sep 20184:01 pmRNSCancellation of Trading and Interim Results
1st Aug 20187:00 amRNSResult of AGM
31st Jul 20183:37 pmRNSPosting of Annual Reports & Accounts
27th Jul 20181:08 pmRNSResult of AGM & Update re Annual Report & Accounts
5th Jul 201810:00 amRNSNotice of Annual General Meeting
2nd Jul 201812:40 pmRNSTrading Update
7th Jun 20187:00 amRNSUpdate on Annual Report and Annual General Meeting
1st May 20187:00 amRNSTrading Update
27th Mar 201812:30 pmRNSSuspension - Nature Group plc
27th Mar 201812:30 pmRNSStatement re. Suspension
19th Mar 20182:47 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSFurther re: Trading Update
7th Mar 20187:00 amRNSTrading Update
17th Nov 201710:56 amRNSStrategic Partner & sale of interest in US
5th Oct 20173:21 pmRNSDirector Loan
29th Sep 20177:07 amRNSInterim Results
9th Aug 20177:00 amRNSDirectorate Change
18th Jul 201710:02 amRNSBoard Changes
30th Jun 201712:07 pmRNSHolding(s) in Company
30th Jun 20178:00 amRNSDirector/PDMR Shareholding
27th Jun 201711:17 amRNSResult of AGM
27th Jun 201710:11 amRNSAGM Statement
15th Jun 20172:37 pmRNSUpdate on Oil & Gas contract
2nd Jun 201710:46 amRNSPosting of Annual Report & Accounts
31st May 20177:00 amRNSFinal Results
18th May 20174:30 pmRNSNotice of Results
21st Apr 20174:18 pmRNSDirector/PDMR Shareholding
13th Apr 20178:00 amRNSTrading Update
24th Mar 20175:49 pmRNSDirector/PDMR Shareholding
6th Feb 20175:23 pmRNSGrant of Options
20th Jan 201712:33 pmRNSHolding(s) in Company
20th Jan 201712:32 pmRNSHolding(s) in Company
18th Jan 20172:38 pmRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSSale of Gibraltar Operations
22nd Dec 201612:01 pmRNSSignificant Oil & Gas Contract Win
9th Dec 20161:03 pmRNSBoard Changes
28th Sep 20167:00 amRNSInterim Results
19th Sep 20164:17 pmRNSAcquisition of Interest in NEMS
29th Jun 20164:13 pmRNSResult of AGM
2nd Jun 20167:00 amRNSAnnual Financial Report
27th May 20167:00 amRNSFinal Results
19th May 201611:42 amRNSNotice of Results
4th Apr 20167:00 amRNSDirectorate Change
15th Feb 20168:15 amRNSTrading Statement
20th Jan 20167:00 amRNSNature Environmental & Marine Services LLC Update
2nd Dec 201512:21 pmRNSProposed Sale of Gibraltar Operations
21st Oct 20157:00 amRNSDirectorate Change
22nd Sep 20157:00 amRNSHalf Yearly Report
15th Sep 201510:05 amRNSNotice of Results
13th Aug 201511:49 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.